| Title |
Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2012
|
| DOI | 10.1002/14651858.cd006100.pub2 |
| Pubmed ID | |
| Authors |
Kirsty Watts, Richard JPG Chavasse |
| Abstract |
Acute asthma presentation in the emergency setting frequently leads to hospital admission. Currently available treatment options include corticosteroid therapy, beta(2)-agonists and oxygen. Antileukotriene agents are beneficial in chronic asthma as additional therapy to inhaled steroids. Their value when used orally or intravenously in the acute setting requires evaluation. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 7 | 39% |
| Chile | 1 | 6% |
| Argentina | 1 | 6% |
| Unknown | 9 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 83% |
| Practitioners (doctors, other healthcare professionals) | 2 | 11% |
| Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 200 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Korea, Republic of | 2 | 1% |
| Colombia | 1 | <1% |
| United States | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 195 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 32 | 16% |
| Researcher | 23 | 12% |
| Student > Bachelor | 15 | 8% |
| Student > Postgraduate | 13 | 7% |
| Other | 11 | 6% |
| Other | 37 | 19% |
| Unknown | 69 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 72 | 36% |
| Nursing and Health Professions | 17 | 9% |
| Social Sciences | 5 | 3% |
| Psychology | 5 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
| Other | 21 | 11% |
| Unknown | 76 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2020.
All research outputs
#2,248,512
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#4,624
of 11,499 outputs
Outputs of similar age
#13,453
of 176,582 outputs
Outputs of similar age from Cochrane database of systematic reviews
#49
of 179 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,582 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.